These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29372493)

  • 41. Hyponatremic encephalopathy caused by desmopressin-induced hyponatremia.
    Ragoschke-Schumm A; Witte OW; Terborg C
    J Neurol; 2005 Nov; 252(11):1411-3. PubMed ID: 15864684
    [No Abstract]   [Full Text] [Related]  

  • 42. Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.
    Yang F; Yang P; Zhang C; Wang Y; Zhang W; Hu H; Wang Z; Qiu X; Jiang T
    Oncotarget; 2017 Jun; 8(26):42974-42982. PubMed ID: 28496000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DDAVP to prevent rapid correction in hyponatremia.
    Goldszmidt MA; Iliescu EA
    Clin Nephrol; 2000 Mar; 53(3):226-9. PubMed ID: 10749304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
    Mock A; Geisenberger C; Orlik C; Warta R; Schwager C; Jungk C; Dutruel C; Geiselhart L; Weichenhan D; Zucknick M; Nied AK; Friauf S; Exner J; Capper D; Hartmann C; Lahrmann B; Grabe N; Debus J; von Deimling A; Popanda O; Plass C; Unterberg A; Abdollahi A; Schmezer P; Herold-Mende C
    Int J Cancer; 2016 Jul; 139(2):424-32. PubMed ID: 26934681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perioperative incidence and management of hyponatremia in vWD patients undergoing adenotonsillectomy.
    Davidson HC; Stapleton AL; Casselbrant ML; Kitsko DJ
    Laryngoscope; 2011 Jul; 121(7):1399-403. PubMed ID: 21647890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma.
    Zhang JF; Chen Y; Lin GS; Zhang JD; Tang WL; Huang JH; Chen JS; Wang XF; Lin ZX
    Hum Pathol; 2016 Jun; 52():136-44. PubMed ID: 26980050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
    Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T
    Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyponatraemic convulsions and fatal head injury secondary to desmopressin treatment for enuresis.
    Larney V; Dwyer R
    Eur J Anaesthesiol; 2006 Oct; 23(10):895-7. PubMed ID: 16953948
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
    Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
    J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
    Rosner MH; Ronco C
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S7-14. PubMed ID: 20653716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in
    Felsberg J; Hentschel B; Kaulich K; Gramatzki D; Zacher A; Malzkorn B; Kamp M; Sabel M; Simon M; Westphal M; Schackert G; Tonn JC; Pietsch T; von Deimling A; Loeffler M; Reifenberger G; Weller M;
    Clin Cancer Res; 2017 Nov; 23(22):6846-6855. PubMed ID: 28855349
    [No Abstract]   [Full Text] [Related]  

  • 52. Metformin influences progression in diabetic glioblastoma patients.
    Adeberg S; Bernhardt D; Ben Harrabi S; Bostel T; Mohr A; Koelsche C; Diehl C; Rieken S; Debus J
    Strahlenther Onkol; 2015 Dec; 191(12):928-35. PubMed ID: 26329695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
    Weller M; Tabatabai G; Kästner B; Felsberg J; Steinbach JP; Wick A; Schnell O; Hau P; Herrlinger U; Sabel MC; Wirsching HG; Ketter R; Bähr O; Platten M; Tonn JC; Schlegel U; Marosi C; Goldbrunner R; Stupp R; Homicsko K; Pichler J; Nikkhah G; Meixensberger J; Vajkoczy P; Kollias S; Hüsing J; Reifenberger G; Wick W;
    Clin Cancer Res; 2015 May; 21(9):2057-64. PubMed ID: 25655102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis of glioblastoma with faint MGMT methylation-specific PCR product.
    Hsu CY; Ho HL; Lin SC; Chang-Chien YC; Chen MH; Hsu SP; Yen YS; Guo WY; Ho DM
    J Neurooncol; 2015 Mar; 122(1):179-88. PubMed ID: 25575938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
    Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
    Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.
    Lam S; Lin Y; Zinn P; Su J; Pan IW
    J Clin Neurosci; 2018 Jan; 47():285-293. PubMed ID: 29102237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fludrocortisone treatment in a child with severe cerebral salt wasting.
    Kinik ST; Kandemir N; Baykan A; Akalan N; Yordam N
    Pediatr Neurosurg; 2001 Oct; 35(4):216-9. PubMed ID: 11694800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of clinical prognostic factors on survival in patients with glioblastoma.
    Tugcu B; Postalci LS; Gunaldi O; Tanriverdi O; Akdemir H
    Turk Neurosurg; 2010 Apr; 20(2):117-25. PubMed ID: 20401838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seizures and coma after desmopressin for nocturnal enuresis.
    Passi GR; Shad R
    Indian Pediatr; 2004 Dec; 41(12):1276-7. PubMed ID: 15623917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.